May 21, 2026 – Boston, MA
Boston Marriott Cambridge, Cambridge, MA
Time
9:00 AM – 5:00 PM
Lunch and networking cocktail hour included
Program
Enhancing Translational Success in Drug Development: The Göttingen Minipig as a Preclinical Model
Lars Siim Madsen, Ellegaard Göttingen Minipigs
Optimizing Targeted CNS Delivery Techniques Using the Göttingen Minipig Model
Erin Slosarek, Labcorp
Minipigs for Optimizing Neurodevelopment in Children with Congenital Heart Disease
Nobuyuki Ishibashi, Boston University
Genetically Modified Minipigs: Advancing Translational Disease Modeling
Chris Rogers, Exemplar Genetics
Planning and Execution of Juvenile Minipig Studies
Jeffrey Klein, SciLucent
Miniature Swine: Considerations for Preclinical Ophthalmic Safety Assessment
Peter J. Sonnentag, Labcorp
CNS Targeted Delivery in the Göttingen Minipig
Maggie Mohr, Northern Biomedical Research
Decoding the Convoluted Neocortex: Leveraging Genetics, Surgical, and Imaging Approaches During Fetal Development Using the Göttingen Minipig
Tarik Haydar, Boston University
Contacts
Ellegaard Bioresearch: +1 410 693 7101 | jca@minipigs.com
Marshall BioResources: +1 315 587 2295 x1117 | phuber@marshallbio.com
Labcorp: +1 617 999 4208 | john.morrissey@labcorp.com